| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 82486 |
多西他赛脂质体，Duoxitasai Liposome |
409 |
axc |
2024-12-24 |
| 82487 |
t-Boc-N-Amido-PEG5-CH2CO2-NHS ester的性质与功能，2743668-40-6 |
190 |
wyh |
2024-12-24 |
| 82488 |
4-Ketobenzotriazine-CH2-S-(CH2)5-COOH,CAS号：221334-33-4 |
236 |
h |
2024-12-24 |
| 82489 |
Fmoc-PEG3-C2-NHS ester,CAS号：1352827-47-4 |
137 |
h |
2024-12-24 |
| 82490 |
DOTA-TATE,CAS:177943-89-4, DOTA-3-酪氨酰基-奥曲肽 |
210 |
zyl |
2024-12-24 |
| 82491 |
Stearic acid-PEG-CH2CO2H, MW 2000 |
160 |
h |
2024-12-24 |
| 82492 |
FmocNH-PEG2-CH2CO2-NHS ester的结构特点，1194666-63-1 |
286 |
wyh |
2024-12-24 |
| 82493 |
Thalidomide-NH-CH2-COOH,CAS号：927670-97-1 |
173 |
h |
2024-12-24 |
| 82494 |
盐酸氨溴索脂质体,Ambroxol Hydrochloride Liposome |
262 |
axc |
2024-12-24 |
| 82495 |
Stearic acid-PEG-CH2CO2H (MW 3400) |
153 |
h |
2024-12-24 |
| 82496 |
CEP1347-VHL-02 |
208 |
h |
2024-12-24 |
| 82497 |
DOTA-GA(tBu)4 cas306776-79-4 大环配体化合物 |
380 |
zyl |
2024-12-24 |
| 82498 |
Z-NH-(CH2)8-NH2·HCl ； N1-叔苄氧羰基-1，8-二氨基辛烷盐酸盐 |
185 |
wyh |
2024-12-24 |
| 82499 |
Stearic acid-PEG-CH2CO2H (MW 5000) |
232 |
h |
2024-12-24 |
| 82500 |
Curcumin Liposome,姜黄素脂质体 |
563 |
axc |
2024-12-24 |
| 82501 |
Stearic acid-PEG-CH2CO2H (MW 1000) |
172 |
h |
2024-12-24 |
| 82502 |
SJF-1528 hemihydrate |
163 |
h |
2024-12-24 |
| 82503 |
Azido-PEG1-CH2CO2H的应用领域，79598-48-4 |
202 |
wyh |
2024-12-24 |
| 82504 |
Ac-Pro-Leu-Val-Glu(OMe)-CH2F |
278 |
h |
2024-12-24 |
| 82505 |
乳酸左氧氟沙星脂质体,Levofloxacin Lactate Liposome |
171 |
axc |
2024-12-24 |
| 82506 |
Azido-PEG1-CH2CO2-NHS的化学结构，2144777-77-3 |
228 |
wyh |
2024-12-24 |
| 82507 |
Tos-PEG1-O-CH2COOH具体解释和潜在应用 |
238 |
h |
2024-12-24 |
| 82508 |
Fmoc-NH-PEG2-CH2COOH,CAS号：166108-71-0,[2-[2-(Fmoc-氨基)乙氧基]乙氧基]乙酸 |
167 |
h |
2024-12-24 |
| 82509 |
Val-cit-PAB-OH，抗体- 药物偶联物，159857-79-1 |
149 |
hyy |
2024-12-24 |
| 82510 |
THP-PEG4-Pyrrolidine(N-Me)-CH2OH,CAS号：2378261-81-3 |
217 |
h |
2024-12-24 |
| 82511 |
Azido-PEG1-CH2CO2-NHS的应用领域，cas:2144777-77-3 |
176 |
wyh |
2024-12-24 |
| 82512 |
THP-PEG4-Pyrrolidine(N-Boc)-CH2OH,CAS号：2378261-80-2 |
159 |
h |
2024-12-24 |
| 82513 |
PEG3-O-CH2COOH,CAS号：51951-05-4,三聚乙二醇-乙酸 |
166 |
h |
2024-12-24 |
| 82514 |
Fmoc-NH-PEG3-amide-CH2OCH2COOH,CAS号：489427-26-1 |
148 |
h |
2024-12-24 |
| 82515 |
Levofloxacin Lactate Liposome,乳酸左氧氟沙星脂质体 |
176 |
axc |
2024-12-24 |
| 82516 |
PROTAC STAT3 degrader-3 |
172 |
h |
2024-12-24 |
| 82517 |
三氧杂十一碳二酸，Azido-PEG5-CH2CO2-PFP |
190 |
wyh |
2024-12-24 |
| 82518 |
Me-triacetyl-β-D-glucopyranuronate-Ph-CH2OH-Fmoc,CAS号：894096-02-7 |
186 |
h |
2024-12-24 |
| 82519 |
Boc-NH-PEG1-Ph-O-CH2COOH,CAS号：2361117-22-6 |
225 |
h |
2024-12-24 |
| 82520 |
Sodium Ferulate Liposome,阿魏酸钠脂质体 |
144 |
axc |
2024-12-24 |
| 82521 |
DSPE-PEG-CH2COOH, MW 2000 |
156 |
h |
2024-12-24 |
| 82522 |
DSPE-PEG-CH2COOH, MW 5000 |
138 |
h |
2024-12-24 |
| 82523 |
6-Maleimidohexanoic acid N-hydroxysuccinimide ester，55750-63-5，ADC试剂 |
217 |
hyy |
2024-12-24 |
| 82524 |
Bis-PEG1-C-PEG1-CH2COOH,CAS号：2358775-67-2 |
190 |
h |
2024-12-24 |
| 82525 |
Azido-PEG5-CH2CO2-PFP的性质与应用，2144777-92-2 |
221 |
wyh |
2024-12-24 |
| 82526 |
Ceftiofur Hydrochloride Liposome,盐酸头孢噻呋脂质体 |
200 |
axc |
2024-12-24 |
| 82527 |
Fmoc-N-PEG-CH2COOH (MW 3400) |
262 |
h |
2024-12-24 |
| 82528 |
N3-PEG3-CH2COOH具体解释和潜在应用 |
137 |
h |
2024-12-24 |
| 82529 |
Flumazenil Liposome,氟马西尼脂质体 |
217 |
axc |
2024-12-24 |
| 82530 |
m-PEG6-O-CH2COOH,CAS号：75427-75-7 |
206 |
h |
2024-12-24 |
齐岳微信公众号
官方微信
库存查询